Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
VIVUS (NQ: VVUS)
+0.00 (0.00%)
at
8.460
2,353,191 in Volume
Add to:
My Watchlist
Data as of 08:10 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 8.310
Bid (Size) 8.020 (200)
Ask (Size) 9.940 (300)
Prev. Close 8.460
Today's Range 8.170 - 8.500
52wk Range 2.720 - 12.88
Shares Outstanding 80,549,780
Morningstar Profile
View Full Profile
VIVUS
The company is engaged in the development and commercialization of therapeutic products for large underserved markets.
Healthcare
Biotechnology
Exchange Traded NQ
Market Cap 681.45M
Related Companies HELE WMGI MATK ARTC
Featured News
Read More
VIVUS to Present at the BIO CEO and Investor Conference
Feb 04, 2010
from PRNewsWire News Releases
VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes
Jan 11, 2010
72% of Attempts at Intercourse in the First 15 Minutes were Successful Read More
from PRNewsWire News Releases
Featured News
Read More
VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea
Jan 07, 2010
from PRNewsWire News Releases
VIVUS To Host Conference Call and Webcast Discussion of Results From Phase 2 Study of Qnexa(R) in Obstructive Sleep Apnea
Jan 06, 2010
from PRNewsWire News Releases
VIVUS to Present at the 2010 JP Morgan Healthcare Conference
Jan 05, 2010
from PRNewsWire News Releases
VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity
Dec 29, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA